OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
32 hedge funds and large institutions have $19.4M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
32
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$190K | |
| 2 | +$146K | |
| 3 | +$86K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$20.3K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$16.1K |
Top Sellers
| 1 | -$549K | |
| 2 | -$177K | |
| 3 | -$165K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$159K |
| 5 |
D.E. Shaw & Co
New York
|
-$120K |